UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q
x 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
þQuarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Or
Or
o¨
 
Transition Report Pursuant to SectionTRANSITION REPORT PURSUANT TO SECTION 13 orOR 15(d) of the Securities Exchange Act ofOF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterperiod ended March 31,June 30, 2002

Commission File No.: 001-16753

AMN HEALTHCARE SERVICES, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
 
06-1500476
Delaware06-1500476
(State or Other Jurisdiction of
Incorporation or Organization)
 
(I.R.S. Employer
Identification No.)
12235 El Camino Real, Suite 200
92130
San Diego, California
 
(Zip Code)92130
(Address of principal executive offices)
 
(Zip Code)

Registrant’s Telephone Number, Including Area Code:    (858) 792-0711

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  þx    No  o¨

As of April 26,August 13, 2002, there were 42,289,77042,985,340 shares outstanding of the registrant’s common stock, par value $0.01 per share.

TABLE OF CONTENTS

PART I -- FINANCIAL INFORMATION
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED STATEMENTS OF OPERATIONS
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures about Market Risk
PART II -- OTHER INFORMATION
Item 2. Changes in Securities and Use of Proceeds
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES

AMN HEALTHCARE SERVICES, INC.

TABLE OF CONTENTS
         
ItemPage
PART I — FINANCIAL INFORMATION
 1.  Consolidated Financial Statements:    
    Consolidated Balance Sheets,    
      As of March 31, 2002 (unaudited) and December 31, 2001.  1 
    Consolidated Statements of Operations,    
      For the Three Months Ended March 31, 2002 and 2001 (unaudited)  2 
    Consolidated Statements of Stockholders’ Equity,    
      For the Three Months Ended March 31, 2002 (unaudited)  3 
    Consolidated Statements of Cash Flows,    
      For the Three Months Ended March 31, 2002 and 2001 (unaudited)  4 
    Notes to Unaudited Consolidated Financial Statements  5 
 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations  9 
 3.  Quantitative and Qualitative Disclosures About Market Risk  14 
PART II — OTHER INFORMATION
 2.  Changes in Securities and Use of Proceeds  15 
 6.  Exhibits and Reports on Form 8-K  15 
    Signatures  16 
Item
     
Page
PART I—FINANCIAL INFORMATION
   
1.  Consolidated Financial Statements:   
   
Consolidated Balance Sheets,
As of June 30, 2002 (unaudited) and December 31, 2001
  1
   
Consolidated Statements of Operations,
For the Three Months and Six Months Ended June 30, 2002 and 2001 (unaudited)
  2
   
Consolidated Statements of Stockholders’ Equity,
For the Six Months Ended June 30, 2002 (unaudited)
  3
   
Consolidated Statements of Cash Flows,
For the Six Months Ended June 30, 2002 and 2001 (unaudited)
  4
   
Notes to Unaudited Consolidated Financial Statements
  5
2.  
Management’s Discussion and Analysis of Financial Condition and Results of Operations
  9
3.  
Quantitative and Qualitative Disclosures About Market Risk
  16
   
PART II—OTHER INFORMATION
   
4.  
Submission of Matters to a Vote of Security Holders
  17
6.  
Exhibits and Reports on Form 8-K
  17
   
Signatures
  18

i

PART I — I—FINANCIAL INFORMATION

Item 1.    

Consolidated Financial Statements

AMN HEALTHCARE SERVICES, INC.
 
CONSOLIDATED BALANCE SHEETS
           
March 31,December 31,
20022001
(Unaudited)
(In thousands, except par value)
ASSETS
        
Current assets:        
 Cash and cash equivalents $25,288  $15,654 
 Short-term held-to-maturity investments  12,166   16,314 
 Accounts receivable, net  125,517   105,416 
 Income taxes receivable  —   4,803 
 Prepaid expenses  8,493   7,810 
 Other current assets  2,327   1,943 
   
   
 
  Total current assets  173,791   151,940 
Fixed assets, net  7,996   7,713 
Deferred income taxes, net  19,385   19,406 
Deposits  306   617 
Goodwill, net  127,752   127,752 
Other intangibles, net  1,391   1,501 
   
   
 
  Total assets $330,621  $308,929 
   
   
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
        
Current liabilities:        
 Bank overdraft $3,069  $1,643 
 Accounts payable and accrued expenses  7,373   5,625 
 Accrued compensation and benefits  28,632   23,965 
 Income taxes payable  2,473   — 
 Other current liabilities  4,229   4,229 
   
   
 
  Total current liabilities  45,776   35,462 
Other long-term liabilities  1,608   1,562 
   
   
 
  Total liabilities  47,384   37,024 
   
   
 
Stockholders’ equity:        
 Common stock, $0.01 par value; 200,000 shares authorized; 42,290 shares issued and outstanding at March 31, 2002 and December 31, 2001  423   423 
 Additional paid-in capital  345,976   345,821 
 Accumulated deficit  (63,162)  (74,339)
   
   
 
  Total stockholders’ equity  283,237   271,905 
   
   
 
Commitments and contingencies        
  Total liabilities and stockholders’ equity $330,621  $308,929 
   
   
 

   
June 30,
2002
     
December 31,
2001
 
   
(Unaudited)
       
   
(In thousands, except par value)
 
ASSETS
            
Current assets:            
Cash and cash equivalents  $30,775     $15,654 
Short-term held-to-maturity investments   9,594      16,314 
Accounts receivable, net   131,403      105,416 
Income taxes receivable   3,857      4,803 
Prepaid expenses   9,556      7,810 
Other current assets   2,703      1,943 
   
    
Total current assets   187,888      151,940 
Fixed assets, net   9,749      7,713 
Deferred income taxes, net   16,432      19,406 
Deposits   1,271      617 
Goodwill, net   135,585      127,752 
Other intangibles, net   1,435      1,501 
   
    
Total assets  $352,360     $308,929 
   
    
LIABILITIES AND STOCKHOLDERS’ EQUITY
            
Current liabilities:            
Bank overdraft  $3,373     $1,643 
Accounts payable and accrued expenses   11,816      5,625 
Accrued compensation and benefits   31,079      23,965 
Other current liabilities   1,115      4,229 
   
    
Total current liabilities   47,383      35,462 
Long-term liabilities   2,761      1,562 
   
    
Total liabilities   50,144      37,024 
   
    
Stockholders’ equity:            
Common stock, $0.01 par value; 200,000 shares authorized; 42,985 and 42,290 shares issued and outstanding at June 30, 2002 and December 31, 2001, respectively   430      423 
Additional paid-in capital   352,467      345,821 
Accumulated deficit   (50,681)     (74,339)
   
    
Total stockholders’ equity   302,216      271,905 
   
    
Commitments and contingencies            
Total liabilities and stockholders’ equity  $352,360     $308,929 
   
    
See accompanying notes to unaudited consolidated financial statements.

1

AMN HEALTHCARE SERVICES, INC.
 
CONSOLIDATED STATEMENTS OF OPERATIONS
           
Three Months Ended
March 31,
20022001
(Unaudited, in thousands,
except per share amounts)
Revenue $173,956  $103,048 
Cost of revenue  131,753   77,919 
   
   
 
  Gross profit  42,203   25,129 
   
   
 
Expenses:        
 Selling, general and administrative, excluding non-cash stock-based compensation  22,725   13,813 
 Non-cash stock-based compensation  218   4,365 
 Amortization  82   1,306 
 Depreciation  691   413 
   
   
 
  Total expenses  23,716   19,897 
   
   
 
  Income from operations  18,487   5,232 
Interest (income) expense, net  (142)  4,325 
   
   
 
  Income before income taxes  18,629   907 
Income tax expense  7,452   471 
   
   
 
  Net income $11,177  $436 
   
   
 
Basic and diluted net income per common share:        
  Basic net income per common share $0.26  $0.02 
   
   
 
  Diluted net income per common share $0.24  $0.01 
   
   
 
Weighted average common shares outstanding — basic  42,290   28,835 
   
   
 
Weighted average common shares outstanding — diluted  46,991   31,431 
   
   
 

   
Three Months Ended June 30,
  
Six Months Ended
June 30,
   
2002
   
2001
  
2002
   
2001
   
(Unaudited, in thousands, except per share amounts)
Revenue  $191,235   $116,124  $365,191   $219,171
Cost of revenue   144,849    86,104   276,602    164,022
   
  
  
  
Gross profit   46,386    30,020   88,589    55,149
   
  
  
  
Expenses:                  
Selling, general and administrative, excluding non-cash stock-based compensation   24,407    17,223   47,132    31,036
Non-cash stock-based compensation   218    4,365   436    8,730
Amortization   92    1,390   174    2,696
Depreciation   737    467   1,428    880
Transaction costs   139    —     139    —  
   
  
  
  
Total expenses   25,593    23,445   49,309    43,342
   
  
  
  
Income from operations   20,793    6,575   39,280    11,807
Interest (income) expense, net   (9)   3,672   (151)   7,997
   
  
  
  
Income before income taxes   20,802    2,903   39,431    3,810
Income tax expense   8,321    1,510   15,773    1,981
   
  
  
  
Net income  $12,481   $1,393  $23,658   $1,829
   
  
  
  
Basic and diluted net income per common share:                  
Basic net income per common share  $0.29   $0.05  $0.56   $0.06
   
  
  
  
Diluted net income per common share  $0.26   $0.04  $0.50   $0.06
   
  
  
  
Weighted average common shares outstanding—basic   42,596    28,835   42,443    28,835
   
  
  
  
Weighted average common shares outstanding—diluted   47,402    31,431   47,198    31,431
   
  
  
  
See accompanying notes to unaudited consolidated financial statements.

2

AMN HEALTHCARE SERVICES, INC.
 
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
                     
Three Months Ended March 31, 2002
Common StockAdditional
Paid-inAccumulated
SharesAmountCapitalDeficitTotal
(Unaudited, in thousands)
Balance, December 31, 2001  42,290  $423  $345,821  $(74,339) $271,905 
Costs of issuance of initial public offering  —   —   (63)  —   (63)
Non-cash stock-based compensation  —   —   218   —   218 
Net income  —   —   —   11,177   11,177 
   
   
   
   
   
 
Balance, March 31, 2002  42,290  $423  $345,976  $(63,162) $283,237 
   
   
   
   
   
 

   
Six Months Ended June 30, 2002
 
   
Common Stock
  
Additional Paid-in Capital
   
Accumulated Deficit
   
Total
 
   
Shares
  
Amount
      
   
(Unaudited, in thousands)
 
Balance, December 31, 2001  42,290  $423  $345,821   $(74,339)  $271,905 
Costs of issuance of common stock  —     —     (942)   —      (942)
Exercise of stock options  695   7   3,124    —      3,131 
Non-cash income tax benefit from stock option exercises  —     —     4,028    —      4,028 
Non-cash stock-based compensation  —     —     436    —      436 
Net income  —     —     —      23,658    23,658 
   
  
  
  
  
Balance, June 30, 2002  42,985  $430  $352,467   $(50,681)  $302,216 
   
  
  
  
  
See accompanying notes to unaudited consolidated financial statements.

3

AMN HEALTHCARE SERVICES, INC.
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
             
Three Months Ended
March 31,
20022001
(Unaudited, in
thousands)
Cash flows from operating activities:        
 Net income $11,177  $436 
 Adjustments to reconcile net income to net cash provided by operating activities:        
  Depreciation and amortization  773   1,719 
  Provision for bad debts  865   520 
  Non-cash interest expense  86   648 
  Deferred income taxes  21   (2,408)
  Non-cash stock-based compensation  218   4,365 
  Changes in assets and liabilities:        
   Accounts receivable  (20,966)  (5,386)
   Income taxes receivable and other current assets  3,736   (1,101)
   Deposits  311   (10)
   Accounts payable and accrued expenses  1,748   1,442 
   Accrued compensation and benefits  4,667   1,812 
   Income taxes payable  2,473   1,242 
   Due to former shareholder  —   (342)
   Other liabilities  9   15 
   
   
 
    Net cash provided by operating activities  5,118   2,952 
   
   
 
Cash flows from investing activities:        
 Proceeds from maturity of short-term held-to-maturity investments  4,148   — 
 Purchase of fixed assets  (948)  (1,019)
   
   
 
    Net cash provided by (used in) investing activities  3,200   (1,019)
   
   
 
Cash flows from financing activities:        
 Capital lease repayments  (30)  (13)
 Payment of financing costs  (17)  — 
 Payments on notes payable  —   (2,029)
 Costs of issuance of common stock  (63)  — 
 Change in bank overdraft  1,426   1,094 
   
   
 
    Net cash provided by (used in) financing activities  1,316   (948)
   
   
 
Net increase in cash and cash equivalents  9,634   985 
Cash and cash equivalents at beginning of period  15,654   546 
   
   
 
Cash and cash equivalents at end of period $25,288  $1,531 
   
   
 
Supplemental disclosures of cash flow information:        
 Cash paid for interest (net of $0 and $21 capitalized in 2002 and 2001, respectively) $62  $2,462 
   
   
 
 Cash paid for income taxes $326  $1,638 
   
   
 
Supplemental disclosures of non-cash investing and financing activities:        
 Accrued interest on notes payable converted to additional notes payable $—  $685 
   
   
 
 Fixed assets obtained through capital leases $26  $— 
   
   
 

   
Six Months Ended June 30,
 
   
2002
     
2001
 
   
(Unaudited, in thousands)
 
Cash flows from operating activities:            
Net income  $23,658     $1,829 
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization   1,602      3,576 
Provision for bad debts   1,961      1,207 
Non-cash interest expense   192      2,960 
Deferred income taxes   52      (4,106)
Non-cash stock-based compensation   436      8,730 
Changes in assets and liabilities, net of effects from acquisitions:            
Accounts receivable   (26,222)     (8,478)
Income taxes receivable and other current assets   5,566      (2,018)
Deposits   (592)     (10)
Accounts payable and accrued expenses   2,852      1,050 
Accrued compensation and benefits   6,715      3,213 
Due to former shareholder   —        (1,341)
Other liabilities   16      65 
   
    
Net cash provided by operating activities   16,236      6,677 
   
    
Cash flows from investing activities:            
Proceeds from maturity of short-term held-to-maturity investments   6,720      —   
Purchase of fixed assets   (2,132)     (1,808)
Acquisitions, net of cash acquired   (9,507)     (12,871)
   
    
Net cash used in investing activities   (4,919)     (14,679)
   
    
Cash flows from financing activities:            
Capital lease repayments   (98)     (29)
Proceeds from issuance of notes payable   —        18,000 
Payment of financing costs   (17)     (629)
Payments on notes payable   —        (6,736)
Proceeds from issuance of common stock, net of issuance costs   2,189      —   
Change in bank overdraft   1,730      (518)
   
    
Net cash provided by financing activities   3,804      10,088 
   
    
Net increase in cash and cash equivalents   15,121      2,086 
Cash and cash equivalents at beginning of period   15,654      546 
   
    
Cash and cash equivalents at end of period  $30,775     $2,632 
   
    
Supplemental disclosures of cash flow information:            
Cash paid for interest (net of $0 and $38 capitalized in 2002 and 2001, respectively)  $125     $4,708 
   
    
Cash paid for income taxes  $7,901     $5,525 
   
    
Supplemental disclosures of non-cash investing and financing activities:            
Accrued interest on notes payable converted to additional notes payable  $—       $1,390 
   
    
Fixed assets obtained through capital leases  $1,222     $2 
   
    
Supplemental disclosures of noncash investing and financing activities:            
Fair value of assets acquired in acquisitions, net of cash received  $2,075     $6,120 
Goodwill   7,833      11,338 
Noncompete covenants   200      200 
Liabilities assumed   (601)     (4,787)
   
    
Net cash paid for acquisitions  $9,507     $12,871 
   
    
See accompanying notes to unaudited consolidated financial statements.

4

AMN HEALTHCARE SERVICES, INC.
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1.    BASIS OF PRESENTATION

The consolidated balance sheets and related consolidated statements of operations, stockholders’ equity and cash flows contained in this Quarterly Report on Form 10-Q, which are unaudited, include the accounts of the CompanyAMN Healthcare Services, Inc. (the Company) and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such financial statements have been included. These entries consisted only of normal recurring items. The results of operations for the interim period are not necessarily indicative of the results that you may expect for the full year.

The consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. Please refer to the Company’s audited consolidated financial statements and the related notes for the year ended December 31, 2001, contained in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.

Certain amounts in the 2001 consolidated financial statements have been reclassified to conform to the 2002 presentation.

2.    EARNINGS PER SHARE

Basic earnings per share (“EPS”)(EPS) excludes dilution and is computed by dividing net income or loss attributable to common stockholders by the weighted-averageweighted average of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock (convertible preferred stock, warrants to purchase common stock and common stock options using the treasury stock method) were exercised or converted into common stock. Potential common shares in the diluted EPS computation are excluded in loss periods as their effect would be anti-dilutive.

The following table sets forth, for the periods indicated, the computation of basic and diluted earnings per share (“EPS”):
         
Three Months Ended
March 31,
20022001
Net earnings $11,177  $436 
   
   
 
Weighted average shares for basic EPS  42,290   28,835 
   
   
 
Basic EPS $0.26  $0.02 
   
   
 
Weighted average shares for basic EPS  42,290   28,835 
Plus stock options  4,701   716 
Plus warrants  —   1,880 
   
   
 
Weighted average shares for diluted EPS  46,991   31,431 
   
   
 
Diluted EPS $0.24  $0.01 
   
   
 
EPS:
   
Three Months Ended June 30,
  
Six Months Ended June 30,
   
2002
  
2001
  
2002
  
2001
Net income  $12,481  $1,393  $23,658  $1,829
   
  
  
  
Weighted average common shares outstanding–basic   42,596   28,835   42,443   28,835
   
  
  
  
Basic net income per common share  $0.29  $0.05  $0.56  $0.06
   
  
  
  
Weighted average common shares outstanding–basic   42,596   28,835   42,443   28,835
Plus stock options   4,806   716   4,755   716
Plus warrants   —     1,880   —     1,880
   
  
  
  
Weighted average common shares outstanding–diluted   47,402   31,431   47,198   31,431
   
  
  
  
Diluted net income per common share  $0.26  $0.04  $0.50  $0.06
   
  
  
  

5

AMN HEALTHCARE SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (continued)STATEMENTS—(Continued)

3.    ACQUISITIONS

On May 1, 2001, AMN Healthcare, Inc., a wholly owned subsidiary of the Company (AMN), acquired 100% of the issued and outstanding stock of O’Grady-Peyton International (USA), Inc. (OGP), a healthcare staffing company specializing in the recruitment of nurses domestically and from English-speaking foreign countries. The acquisition was recorded using the purchase method of accounting. TheThus, the results of operations from the acquired assets are included in the Company’s consolidated financial statements includefrom the operatingacquisition date.
On April 23, 2002, AMN acquired 100% of the issued and outstanding stock of Healthcare Resource Management Corporation (HRMC), a nationwide provider of travel healthcare staffing. The acquisition was recorded using the purchase method of accounting. Thus, the results of OGPoperations from the acquired assets are included in the Company’s consolidated financial statements from the acquisition date. The purchase price paid to the former stockholders of HRMC included a payment of $8,561,000 in cash (net of $199,000 cash received), and $400,000 which was delivered to an escrow agent on the acquisition date in accordance with the purchase agreement. The funds held in escrow are to be released to the former shareholders on April 23, 2003.
AMN acquired HRMC’s assets of acquisition. $2,070,000 (net of cash received), assumed its liabilities of $597,000 and recorded goodwill in the amount of $7,424,000, which is not subject to amortization under the provisions of Statement of Accounting Standards (SFAS) No. 142 (see Note 5) and is tax deductible in its entirety. AMN allocated $200,000 of the purchase price to the noncompete agreement, which is being amortized over the four-year life of the agreement.
Unaudited pro forma operating results for the Company, assuming the acquisitionacquisitions of OGP and HRMC had been made at the beginning of the three month period ended March 31, 2001,periods presented, are as follows (in thousands, except per share amounts):
     
Revenue $110,823 
Income from operations  6,374 
Net income  1,128 
   
 
Earnings per share — basic $0.04 
   
 
Earnings per share — diluted $0.04 
   
 
Weighted average shares — basic  28,835 
   
 
Weighted average shares — diluted  31,431 
   
 

   
Six Months Ended June 30,
   
2002
    
2001
Revenue  $369,922    $235,931
Income from operations   39,674     13,915
Net income  $23,967    $3,219
   
    
Basic net income per common share  $0.56    $0.11
   
    
Diluted net income per common share  $0.51    $0.10
   
    
Weighted average common shares outstanding–basic   42,443     28,835
   
    
Weighted average common shares outstanding–diluted   47,198     31,431
   
    
4.    COMPREHENSIVE INCOME

SFAS No. 130,Reporting Comprehensive Income, establishes rules for the reporting of comprehensive income and its components. Comprehensive income includes items such as effective gains and losses on foreign currency forward exchange contracts, foreign currency translation adjustments, and unrealized holding gains and losses on available-for-sale securities. For the threesix months ended March 31,June 30, 2002, comprehensive income equaled net income.

5.     EARN-OUT PROVISIONS

     The Company is liable for an earnout payment of $3,141,000 relating to its acquisition of OGP. The Company accrued $3,141,000 for this earn-out provision and recorded this amount as additional goodwill and other current liabilities as of December 31, 2001. There is also additional contingent consideration of up to $2,369,000 dependent upon collection of an outstanding receivable from a customer of OGP if received prior to May 2002.

6.    NEW ACCOUNTING PRONOUNCEMENTS

In July 2001, the FASBFinancial Accounting Standards Board (FASB) issued SFAS No. 141,Business Combinations, and SFAS No. 142,Goodwill and Other Intangible Assets. SFAS No. 141 requires the use of the purchase method for all business combinations initiated after June 30, 2001 and provides guidance on purchase accounting related to the recognition of intangible assets and accounting for negative goodwill. SFAS No. 142 changes the accounting for goodwill from an amortization method to an impairment-only approach. Under SFAS

AMN HEALTHCARE SERVICES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

No. 142, goodwill will be tested annually and whenever events or circumstances occur indicating that goodwill might be impaired.

The Company adopted the provisions of SFAS No. 142 as of January 1, 2002. Upon adoption of SFAS No. 142, the Company ceased amortization of goodwill and performed the two-step transitional impairment test. SFAS No. 142 requires the impairment test be applied to the relevant “reporting unit” which may differ from the specific entities acquired from which the goodwill arose. Due to the integrated nature of the Company’s operations and lack of differing economic characteristics betweenamong the Company’s subsidiaries, the entire Company was determined to be one single reporting unit.

6

AMN HEALTHCARE SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (continued)

As of the date of adoption of SFAS No. 142, January 1, 2002, the Company had unamortized goodwill in the amount of $127,752,000 and unamortized identifiable intangible assets acquired in business combinations in the amount of $871,000, all of which are subject to the transition provisions of SFAS Nos. 141 and 142. Amortization expense related to goodwill was $1,236,000$2,548,000 for the threesix months ended March 31,June 30, 2001. The Company adopted SFAS No. 142 as of January 1, 2002, performed the two-step transitional goodwill impairment test and determined there was no impairment as of January 1, 2002. The Company has also re-evaluated the classifications of its existing intangible assets and goodwill in accordance with SFAS No. 141 and has determined that the current classifications conform with the criteria in SFAS No. 141.

As of March 31,June 30, 2002 and December 31, 2001, the Company had the following acquired intangible assets with definite lives (in thousands):
                 
March 31, 2002December 31, 2001
GrossGross
carryingAccumulatedcarryingAccumulated
amountamortizationamountamortization
Non-compete agreements $1,336  $(548) $1,336  $(465)
Deferred financing costs  649   (46)  633   (3)
   
   
   
   
 
Total $1,985  $(594) $1,969  $(468)
   
   
   
   
 

   
June 30, 2002
   
December 31, 2001
 
   
Gross
carrying
amount
    
Accumulated
amortization
   
Gross
carrying
amount
    
Accumulated
amortization
 
Noncompete agreements  $1,536    $(639)  $1,336    $(465)
Deferred financing costs   649     (111)   633     (3)
   
    
  
    
Total  $2,185    $(750)  $1,969    $(468)
   
    
  
    
Aggregate amortization expense for the intangible assets presented in the above table was $126,000$282,000 and $407,000$852,000 for the threesix months ended March 31,June 30, 2002 and March 31,June 30, 2001, respectively. Amortization of deferred financing costs is included in interest expense. Estimated annual future aggregate amortization expense as of March 31,June 30, 2002 areis as follows (in thousands):
     
Amount
Nine months ending December 31, 2002 $443 
Year ending December 31, 2003 $544 
Year ending December 31, 2004 $387 
Year ending December 31, 2005 $17 

7

AMN HEALTHCARE SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (continued)

   
Amount
Six months ending December 31, 2002  $320
Year ending December 31, 2003  $594
Year ending December 31, 2004  $438
Year ending December 31, 2005  $67
Year ending December 31, 2006  $16
As of March 31,June 30, 2002 and December 31, 2001, the Company had unamortized goodwill of $135.6 million and $127.8 million. million, respectively. The changes in the carrying amount of goodwill for the six months ended June 30, 2002 are as follows (in thousands):
   
Amount
Goodwill, as of December 31, 2001  $127,752
Goodwill acquired   7,833
   
Goodwill as of June 30, 2002  $135,585
   

AMN HEALTHCARE SERVICES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following reconciliation adjusts net income for amortization expense related to goodwill that is no longer amortized under SFAS No. 142, net of tax (in thousands, except per share data):
           
March 31,
20022001
Net income $11,177  $436 
Goodwill amortization, net of tax  —   593 
   
   
 
Adjusted net income $11,177  $1,029 
   
   
 
 
Basic net income per common share:        
 Net income per common share $0.26  $0.02 
 Goodwill amortization per common share  —   0.02 
   
   
 
  Adjusted net income per common share $0.26  $0.04 
   
   
 
 
Diluted net income per common share:        
 Diluted net income per common share $0.24  $0.01 
 Diluted goodwill amortization per common share  —   0.02 
   
   
 
  Adjusted diluted net income per common share $0.24  $0.03 
   
   
 

7. SUBSEQUENT EVENTS

     On April 2, 2002, the Company signed a 15-year lease for a new corporate headquarters in San Diego, California commencing in August 2003. As a result, the Company has future minimum lease payments of approximately $123 million to be paid over the next 15 years under this lease.

     On April 23, 2002, the Company acquired all of the outstanding stock of Healthcare Resource Management Corporation, a nationwide travel healthcare staffing company located in Charlotte, North Carolina, for $9.3 million in cash. Healthcare Resource Management Corporation recruits and places temporary healthcare professionals in the United States under the brand name “HRMC.” In conjunction with the acquisition, the Company paid an affiliate $139,000 for advisory services.

8

 
Item 2.     Management’s Discussion and Analysis of Financial Condition and Results of Operations
   
June 30,
   
2002
  
2001
Net income, as reported  $23,658  $1,829
Goodwill amortization, net of tax   —     1,223
   
  
Adjusted net income  $23,658  $3,052
   
  
Basic net income per common share:        
Net income per common share, as reported  $0.56  $0.06
Goodwill amortization per common share   —     0.04
   
  
Adjusted net income per common share–basic  $0.56  $0.10
   
  
Diluted net income per common share:        
Diluted net income per common share, as reported  $0.50  $0.06
Goodwill amortization per common share   —     0.04
   
  
Adjusted net income per common share–diluted  $0.50  $0.10
   
  

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with, and is qualified in its entirety by, our financial statements and the notes thereto and other financial information included elsewhere herein and in our Annual Report on Form 10-K for the year ended December 31, 2001. Certain statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are “forward-looking statements.” See “— Special Note Regarding Forward-Looking Statements.”

Overview

We are a leading temporary healthcare staffing company and the largest nationwide provider of travel nurse staffing services, one of the fastest growing segments of the temporary healthcare staffing industry. We recruit nurses and allied health professionals, our “temporary healthcare professionals,” and place them on temporary assignments, typically for 13 weeks away from their permanent homes, at hospitals and healthcare facilities throughout the United States.

We market our services to two distinct customer bases: (1) hospitals and healthcare facilities and (2) nurses and allied healthcare professionals. We have established a geographically diverse hospital and client base, ranging from national healthcare providers to premier teaching and regional hospitals. We currently hold contracts with over 40% of all acute-care hospitals in the United States, which provide our temporary healthcare professionals with a broad selection of assignments in all regions of the country. Our hospital and healthcare facility clients utilize our services to help manage staff shortages, flexible staffing models, new unit openings, seasonal patient census variations, and other short and long-term staffing needs. Nurses and allied healthcare professionals join us for a variety of reasons, including to seek flexible work opportunities, to travel to different areas of the country, to build their clinical skills and resume by working at prestigious healthcare facilities, to escape the demands and political environment of working as a permanent staff nurse, and to earn attractive compensation and benefit packages.
To enhance our ability to successfully attract temporary healthcare professionals, we use a multi-brand recruiting strategy to recruit in the United States and internationally under our six separate brands. Our multi-brand strategy offers temporary healthcare professionals a selection of brands and recruitment teams, which we believe enhances our ability to attract more new candidates. We believe that we have organized our operating model to deliver consistent, high-quality sales and service efforts to our two client bases. Processes within our operating model have been developed and are in place with the intent to maximize the quantity and quality of assignment requests (orders) from our hospital clients and increase the expediency and probability of successfully placing our temporary healthcare professionals. The consistent quality of the benefit and support services which we provide to our temporary healthcare professionals is also critical to our growth and success, since the majority of our travelers stay with us for multiple assignments and our largest source of new candidates is word-of-mouth referrals from satisfied current and former temporary healthcare professionals.
We derive substantially all of our revenue from fees paid directly by hospitals and healthcare facilities rather than from payments by government or other third parties. We enter into two types of contracts with our hospital and healthcare facility clients: flat rate contracts and payroll contracts. Under a flat rate contract, the temporary healthcare professional becomes an employee of the hospital or healthcare facility and is placed on their payroll. We bill the hospital or healthcare facility a “flat” weekly rate to compensate us for providing recruitment, housing and travel services. Alternatively, under a payroll contract, the temporary healthcare professional is our employee. We then bill our hospital or healthcare facility client at an hourly rate to compensate us for the temporary healthcare professional’sprofessionals’ wages and benefits, as well as for recruitment, housing and travel services. Our clients generally prefer payroll contracts because this arrangement eliminates significant employee and payroll administrative burdens for them. Although the temporary healthcare professional wage and benefits billed under a payroll contract primarily represent a pass-through cost component for us, we are able to generate greater profits by providing these value-added services. While payroll contracts generate more gross profit than flat rate

contracts, the gross margin generated is lower due to the pass-through of the temporary healthcare professional’s compensation costs. Over the past five years, we, and the industry as a whole, have migrated towards a greater utilization of payroll contracts. During the threesix months ended March 31,June 30, 2002, approximately 96%97% of our contracts with our hospital and healthcare facility clients were payroll contracts.

Since 1998, we have completed five strategic acquisitions. We acquired Medical Express, Inc. in November 1998, which strengthened our presence in the Pacific Northwest and Mountain states. During 2000, we completed the acquisitions of Nurses RX, Inc. in June, and Preferred Healthcare Staffing, Inc. in November, which strengthened our presence in the Eastern and Southern regions of the United States. InWe completed our fourth acquisition in May 2001, we acquiredacquiring O’Grady-Peyton International (USA), Inc., the leading recruiter of registered nurses from English-speaking foreign countries for placement in the United States. In April 2002, we completed the acquisition of Healthcare Resource Management Corporation, further strengthening our presence in the Eastern and Southern regions of the United States. Each of these acquisitions has been accounted for by the purchase method of accounting. Therefore, the operating results of the acquired entities are included in our results of operations commencing on the date of acquisition of each entity. As a result, our results of operations following each acquisition may not be comparable with our prior results.

     Upon

At the completion of our initial public offering in November 2001, options to purchase 5,182,000 shares of our common stock that we granted to members of our management became immediately vested. These options had an average exercise price $12.45 below the initial public offering price of $17.00 per share. As a result, we recorded approximately $18.8 million of non-cash stock-based compensation expense in the fourth quarter of 2001, of which $18.7 million was related to these options. In addition, we also recorded $13.1 million of non-cash stock-based compensation expense in the first three quarters of 2001 and $22.4 million in fiscal year 2000. We also retired all of our indebtedness (approximately $145.2 million) with the proceeds from and upon the completion of our initial public offering. The retirement of debt resulted in an extraordinary charge against earnings of approximately $5.5 million, net of income tax benefit, related to the

9

write-off of the unamortized discount on our senior subordinated notes and unamortized deferred financing costs and loan fees resulting from the early extinguishment of our existing indebtedness, and a prepayment premium resulting from the early extinguishment of the senior subordinated notes.

Critical Accounting Principles and Estimates

In response to the SEC’s Release Numbers 33-8040 “Cautionary Advice Regarding Disclosure About Critical Accounting Policies” and 33-8056, “Commission Statement about Management’s Discussion and Analysis of Financial Condition and Results of Operations,” we have identified the following critical accounting policies that affect the more significant judgments and estimates used in the preparation of our unaudited consolidated financial statements. The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to asset impairment, accruals for self-insurance and compensation and related benefits, revenue recognition, allowance for doubtful accounts, and contingencies and litigation. We state these accounting policies in the notes to the audited consolidated financial statements and related notes for the year ended December 31, 2001, contained in our Annual Report of Form 10-K as filed with the Securities and Exchange Commission, and in relevant sections in this discussion and analysis. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could vary from those estimates under different assumptions or conditions.

We believe that the following critical accounting policies affect the more significant judgments and estimates used in the preparation of our unaudited consolidated financial statements:

 •
We have recorded goodwill and intangibles resulting from our acquisitions completed in the past four years. Through December 31, 2001, goodwill and intangibles were amortized on a straight-line basis over their lives of 25 years and four years, respectively. Upon the adoption of SFAS No. 142 on January 1, 2002, we ceased amortizing goodwill and will perform an annual impairment analysis to assess the recoverability of the goodwill, in accordance with the provisions of SFAS No. 142. If we are required to record an impairment charge in the future, it would have an adverse impact on our results of operations.

over their lives of 25 years and 4 years, respectively. Upon the adoption of SFAS No. 142 on January 1, 2002, we ceased amortizing goodwill and performed an annual impairment analysis to assess the recoverability of the goodwill, in accordance with the provisions of SFAS No. 142. If we are required to record an impairment charge in the future, it would have an adverse impact on our results of operations.
 •
We maintain an accrual for our health and workers compensation self-insurance, which is classified in accrued compensation and benefits in our consolidated balance sheets. We determine the adequacy of these accruals by periodically evaluating our historical experience and trends related to both health and workers compensation claims and payments, information provided to us by our insurance broker and industry experience and trends. If such information indicates that our accruals are overstated or understated, we will adjust the assumptions utilized in our methodologies and reduce or provide for additional accruals as appropriate.
 •
We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments, which results in provision for bad debt expense. We determine the adequacy of this allowance by continually evaluating individual customer receivables, considering the customer’s financial condition, credit history and current economic conditions. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.
 •
We are subject to various claims and legal actions in the ordinary course of our business. Some of these matters include professional liability, employee-related matters and investigations by governmental agencies regarding our employment practices. As we become aware of such claims and legal actions, we provide accruals as appropriate. Our hospital and healthcare facility clients may also become subject to claims, governmental inquiries and investigations and legal actions to which we may become a party relating to services provided by our professionals. From time to time, and depending upon the particular facts and circumstances, we may be subject to indemnification obligations under our contracts with our hospital and healthcare facility clients relating to these matters. Although we are

10

currently not aware of any such pending or threatened litigation that we believe is reasonably likely to have a material adverse effect on us, if we become aware of such claims against us, we will evaluate the probability of an adverse outcome and provide accruals for such contingencies as necessary.

Results of Operations

The following table sets forth, for the periods indicated, certain statement of operations data as a percentage of our revenue. Our results of operations are reported as a single business segment.
         
Three Months
Ended March 31,
20022001
Consolidated Statement of Operations:
        
Revenue  100.0%  100.0%
Cost of revenue  75.7   75.6 
   
   
 
Gross profit  24.3   24.4 
Selling, general and administrative (excluding non-cash stock-based compensation)  13.1   13.4 
Non-cash stock-based compensation  0.2   4.2 
Amortization and depreciation expense  0.4   1.7 
   
   
 
Income from operations  10.6   5.1 
Interest (income) expense, net  (0.1)  4.2 
   
   
 
Income before income taxes  10.7   0.9 
Income tax expense  4.3   0.5 
   
   
 
Net income  6.4%  0.4%
   
   
 
 
Comparison of Results for the Three Months Ended March 31, 2002 to the Three Months Ended March 31, 2001
   
Three Months Ended
June 30,
     
Six Months Ended
June 30,
 
   
2002
     
2001
     
2002
     
2001
 
Consolidated Statement of Operations:
                      
Revenue  100.0%    100.0%    100.0%    100.0%
Cost of revenue  75.7     74.1     75.7     74.8 
   
    
    
    
Gross profit  24.3     25.9     24.3     25.2 
Selling, general and administrative (excluding non-cash stock-based compensation)  12.8     14.8     12.9     14.2 
Non-cash stock-based compensation  0.1     3.8     0.1     4.0 
Amortization and depreciation expense  0.4     1.6     0.4     1.6 
Transaction costs  0.1     0.0     0.0     0.0 
   
    
    
    
Income from operations  10.9     5.7     10.9     5.4 
Interest (income) expense, net  0.0     3.2     0.0     3.6 
   
    
    
    
Income before income taxes  10.9     2.5     10.9     1.8 
Income tax expense  4.4     1.3     4.3     0.9 
   
    
    
    
Net income  6.5%    1.2%    6.6%    0.9%
   
    
    
    

Comparison of Results for the Three Months Ended June 30, 2002 to the Three Months Ended June 30, 2001
Revenue.Revenue increased 69%65%, from $103.0$116.1 million for the first three months ofended June 30, 2001 to $174.0$191.2 million for the same period in 2002. Of the $71.0$75.1 million increase, approximately $60.2$68.4 million was attributable to organic growth of our existing brands through growth in the number of temporary healthcare professionals and enhancements in contract terms with our hospital and healthcare facility clients, representing an organic growth rate for our recurring operations of 58%59%. The total number of temporary healthcare professionals on assignment in our existing brands grew 33% and contributed approximately $34.1$38.2 million to the increase. Enhancements in contract terms which included increases in average hourly rates charged to hospital and healthcare facility clients accounted for approximately $19.7$24.1 million of this increase, and a shift in the mix of payroll versus flat rate temporary healthcare professional contracts accounted for approximately $6.4$6.1 million of this increase. The remainder of the increase, $10.8$6.7 million, was attributable to the acquisitionacquisitions of O’Grady-Peyton International (OGP) in May 2001.2001 and Healthcare Resource Management Corporation (HRMC) in April 2002.

Cost of Revenue.Cost of revenue increased 69%68%, from $77.9$86.1 million for the three months ended March 31,June 30, 2001 to $131.8$144.8 million for the same period in 2002. Of the $53.9$58.7 million increase, approximately $46.5$54.1 million was attributable to the organic growth of our existing brands, and approximately $7.4$4.6 million was attributable to the acquisitionacquisitions of O’Grady-Peyton International.OGP and HRMC.

Gross Profit.Gross profit increased 68%55%, from $25.1$30.0 million for the three months ended March 31,June 30, 2001 to $42.2$46.4 million for the same period in 2002, representing gross margins of 24.4%25.9% and 24.3%, respectively. The decrease in gross margin was primarily attributable to the shift in mix from flat rate to payroll contracts and a greater pass-through of bill rate increases to our travelers. Of the $17.1$16.4 million increase in gross profit, approximately $13.7$14.3 million was attributable to the organic growth of our existing brands and approximately $3.4$2.1 million was attributable to the acquisitionacquisitions of O’Grady-Peyton International.OGP and HRMC.

11

Selling, General and Administrative Expenses.Selling, general and administrative expenses increased 64%42%, from $13.8$17.2 million for the three months ended March 31,June 30, 2001 to $22.7$24.4 million for the same period in 2002. Of the $8.9$7.2 million increase, approximately $2.4$1.4 million was attributable to the acquisitionacquisitions of O’Grady-Peyton International.OGP and HRMC. The remaining increase of $6.5$5.8 million was primarily attributable to increases in recruiting, information systems development, marketing, administrative and office expenses and nurse education and professional development information systems development, marketing, recruiting, and administrative and office expenses in support of the recent and anticipated growth in temporary healthcare professionals under contract.

Non-Cash Stock-Based Compensation.We recorded non-cash compensation charges of $4.4 million for the three months ended March 31,June 30, 2001 and $0.2 million for the same period in 2002 in connection with our stock option plans to reflect the difference between the fair market value and the exercise price of previously issued stock options. The decrease of $4.2 million is attributable to the vesting of the majority of these options upon the completion of our initial public offering in November 2001.

Amortization and Depreciation Expense.Amortization expense decreased from $1.3$1.4 million for the three months ended March 31,June 30, 2001 to less than $0.1 million for the same period in 2002. This decrease was attributable to the adoption of SFAS No. 142,Goodwill and Other Intangible Assets, effective January 1, 2002, under which goodwill amortization was ceased. Depreciation expense increased from $0.4$0.5 million for the three months ended March 31,June 30, 2001 to $0.7 million for the three months ended March 31,June 30, 2002. This increase was primarily attributable to internally developed software placed in service in 2001.

Interest (Income) Expense, Net.Interest (income) expense, net was expense of $4.3$3.7 million for the three months ended March 31,June 30, 2001 as compared to income of $0.1 millionnine thousand dollars for the same period in 2002. Of the $4.4$3.7 million change, approximately $4.3$3.5 million was attributable to the retirement of all of our indebtedness (approximately $145.2 million) with the proceeds from and upon the completion of our initial public offering in November 2001.

Income Tax Expense.The provision for income    Income tax expense for the three months ended March 31,June 30, 2001 was $0.5$1.5 million as compared to $7.5$8.3 million for the three months ended March 31,June 30, 2002, reflecting effective income tax rates of 52% and 40% for these periods, respectively. The difference between the effective tax rate for the first three months ofended June 30, 2001 and our expected effective tax rate of 41% for that period is primarily attributable to the effect of various permanent tax difference items, the impact of which is magnified by the reduction in pre-tax income due to the non-cash stock-based compensation expense.
Comparison of Results for the Six Months Ended June 30, 2002 to the Six Months Ended June 30, 2001
Revenue.    Revenue increased 67%, from $219.2 million for the six months ended June 30, 2001 to $365.2 million for the same period in 2002. Of the $146.0 million increase, approximately $128.6 million was attributable to organic growth of our existing brands through growth in the number of temporary healthcare professionals and enhancements in contract terms with our hospital and healthcare facility clients, representing an organic growth rate for our recurring operations of 59%. The total number of temporary healthcare professionals on assignment in our existing brands grew 33% and contributed approximately $72.3 million to the increase. Enhancements in contract terms which included increases in average hourly rates charged to hospital and healthcare facility clients accounted for approximately $43.7 million of this increase, and a shift in the mix of payroll versus flat rate temporary healthcare professional contracts accounted for approximately $12.6 million of this increase. The remainder of the increase, $17.4 million, was attributable to the acquisitions OGP in May 2001 and HRMC in April 2002.
Cost of Revenue.    Cost of revenue increased 69%, from $164.0 million for the six months ended June 30, 2001 to $276.6 million for the same period in 2002. Of the $112.6 million increase, approximately $100.6 million was attributable to the organic growth of our existing brands, and approximately $12.0 million was attributable to the acquisitions of OGP and HRMC.
Gross Profit.    Gross profit increased 61%, from $55.1 million for the six months ended June 30, 2001 to $88.6 million for the same period in 2002, representing gross margins of 25.2% and 24.3%, respectively. The decrease in gross margin was primarily attributable to the shift in mix from flat rate to payroll contracts and a greater pass-through of bill rate increases to our travelers. Of the $33.4 million increase in gross profit, approximately $28.0 million was attributable to the organic growth of our existing brands and approximately $5.4 million was attributable to the acquisitions of OGP and HRMC.
Selling, General and Administrative Expenses.    Selling, general and administrative expenses increased 52%, from $31.0 million for the six months ended June 30, 2001 to $47.1 million for the same period in 2002. Of the $16.1 million increase, approximately $3.8 million was attributable to the acquisitions of OGP and HRMC. The remaining increase of $12.3 million was primarily attributable to increases in recruiting, information systems development, marketing, administrative and office expenses and nurse education and professional development in support of the recent and anticipated growth in temporary healthcare professionals under contract.
Non-Cash Stock-Based Compensation.    We recorded non-cash compensation charges of $8.7 million for the six months ended June 30, 2001 and $0.4 million for the same period in 2002 in connection with our stock option plans to reflect the difference between the fair market value and the exercise price of previously issued stock options. The decrease of $8.3 million is attributable to the vesting of the majority of these options upon the completion of our initial public offering in November 2001.
Amortization and Depreciation Expense.    Amortization expense decreased from $2.7 million for the six months ended June 30, 2001 to $0.2 million for the same period in 2002. This decrease was attributable to the adoption of SFAS No. 142, effective January 1, 2002, under which goodwill amortization ceased. Depreciation expense increased from $0.9 million for the six months ended June 30, 2001 to $1.4 million for the six months ended June 30, 2002. This increase was primarily attributable to internally developed software placed in service in 2001.

Interest (Income) Expense, Net.    Interest (income) expense, net was expense of $8.0 million for the six months ended June 30, 2001 as compared to income of $0.2 million for the same period in 2002. Of the $8.2 million change, approximately $7.7 million was attributable to the retirement of all of our indebtedness (approximately $145.2 million) with the proceeds from and upon the completion of our initial public offering in November 2001.
Income Tax Expense.    Income tax expense for the six months ended June 30, 2001 was $2.0 million as compared to $15.8 million for the six months ended June 30, 2002, reflecting effective income tax rates of 52% and 40% for these periods, respectively. The difference between the effective tax rate for the six months ended June 30, 2001 and our expected effective tax rate of 41% for that period is primarily attributable to the effect of various permanent tax difference items, the impact of which is magnified by the reduction in pre-tax income due to the non-cash stock-based compensation expense.
Liquidity and Capital Resources

Historically, our primary liquidity requirements have been for debt service under our credit facility, acquisitions and working capital requirements. We have funded these requirements through internally generated cash flow and funds borrowed under our existing credit facility. At March 31,June 30, 2002, we had no debt outstanding under our revolving credit facility. Upon the completion of our initial public offering in November 2001, we amended and restated our credit agreement in order to eliminate all of our term loans and to provide for a secured revolving credit facility of up to $50$50.0 million in borrowing capacity. The revolving credit facility has a maturity date of November 16, 2004 and contains a letter of credit sub-facility and a swing-line loan sub-facility. Borrowings under this revolving credit facility bear interest at floating rates based upon either a LIBOR or prime interest rate option selected by us, plus a spread, to be determined based on the outstanding amount of the revolving credit facility. Our amended and restated credit agreement contains a minimum fixed charge coverage ratio, a maximum leverage ratio and other customary covenants. Amounts available under our revolving credit facility may be used for working capital and general corporate purposes, subject to various limitations.

We have relatively low capital investment requirements. Capital expenditures were $1.0$1.8 million and $0.9$2.1 million for the threesix months ended March 31,June 30, 2001 and 2002, respectively. For the first threesix months of 2002, our primary capital expenditures were $0.4$1.0 million for purchased and internally developed software and $0.5$1.1 million for computers, furniture and equipment and other expenditures. We expect our capital expenditure requirements as a percentage of revenue to be similar in the future, other than costs related to our new corporate headquarters, including leasehold improvements, furniture and equipment.

12

equipment (which we expect to range between $6.0 million and $8.0 million in 2003).

Our principal working capital need is for accounts receivable, which has increased with the growth in our business. Our principal sources of cash to fund our working capital needs are cash generated from operating activities and borrowings under our revolving credit facility. Net cash provided by operations increased from $3.0for the six months ended June 30, 2001 was $6.7 million as compared to $16.2 million for the threesix months ended March 31, 2001 to $5.1 million for the three months ended March 31,June 30, 2002, resulting primarily due tofrom cash earnings generated by us, offset by the growth in our cash earnings offset by an increase in working capital.

We believe that cash generated from operations, the remaining net proceeds from our initial public offering and borrowings under our revolving credit facility will be sufficient to fund our operations for the next 12 months. On April 23, 2002, we acquired Healthcare Resource Management Corporation for $9.3 million in cash. We expect to be able to finance any future acquisitions either with cash provided from operations, borrowings under our revolving credit facility, bank loans, debt or equity offerings, or some combination of the foregoing.

At March 31,June 30, 2001 and March 31, 2002, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts. As

such, we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships. We do not have relationships or transactions with persons or entities that derive benefits from their non-independent relationship with us or our related parties other than relationships described in our Annual Report on Form 10-K for the year ended December 31, 2001.

Potential Fluctuations in Quarterly Results and Seasonality

Due to the regional and seasonal fluctuations in the hospital patient census of our hospital and healthcare facility clients and due to the seasonal preferences for destinations by our temporary healthcare professionals, the number of temporary healthcare professionals on assignment, revenue and earnings are subject to moderate seasonal fluctuations. Many of our hospital and healthcare facility clients are located in areas that experience seasonal fluctuations in population, such as Florida and Arizona, during the winter and summer months. These facilities adjust their staffing levels to accommodate the change in this seasonal demand and many of these facilities utilize temporary healthcare professionals to satisfy these seasonal staffing needs.

Historically the number of our temporary healthcare professionals on assignment has increased during January through March followed by declines or minimal growth during April through August. During September through November, our temporary healthcare professional count has historically increased, followed by a decline in December. Seasonality of revenue and earnings is expected to continue. As a result of all of these factors, results of any one quarter are not necessarily indicative of the results to be expected for any other quarter or for any year.

Recent Accounting Pronouncements

In August 2001, the FASB issued SFAS No. 143,Accounting for Asset Retirement Obligations, which addresses financial accounting and reporting for obligations associated with the retirement of tangible long-lived assets and for the associated asset retirement costs. The standard applies to tangible long-lived assets that have a legal obligation associated with their retirement that results from the acquisition, construction or development or normal use of the asset. SFAS No. 143 requires that the fair value of a liability for an asset retirement obligation be recognized in the period in which it is incurred if a reasonable estimate of fair value can be made. The fair value of the liability is added to the carrying amount of the associated asset and this additional carrying amount is depreciated over the remaining life of the asset. The liability is accreted at the end of each period through charges to operating expense. SFAS No. 143 is effective for fiscal years beginning after June 15, 2002. We do not anticipate that the financial impact of this statement will have a material effect on our consolidated financial statements.

In October 2001,April 2002, the FASB issued SFAS No. 144,145,Accounting forRescission of FASB Statements No. 4, 44 and 64, Amendment of FASB Statement No. 13, and Technical Corrections, which provides guidance on the Impairment or Disposalclassification of Long-Lived Assets, which addresses financial accountinggains and reporting forlosses from the impairment or disposalextinguishment of long-lived assets. While SFAS No. 144 supersedes SFAS No. 121,Accounting for the Impairment of Long-Lived Assets

13

debt and for Long-Lived Assets to Be Disposed Of, it retains many of the fundamental provisions of SFAS No. 121, including the recognition and measurement of the impairment of long-lived assets to be held and used, and the measurement of long-lived assets to be disposed of by sale. SFAS No. 144 also supersedeson the accounting and reporting provisions of Accounting Principles Board Opinion (APB) No. 30,Reporting the Results of Operations-Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions,for the disposal of a segment of a business. However, it retains the requirement in APB No. 30 to report separately discontinued operations and extends that reporting to a component of an entity that either has been disposed of (by sale, abandonment, or in a distribution to owners) or is classified as held for sale. SFAS No. 144 is effective for fiscal years beginning after December 15, 2001.certain specified lease transactions. We do not anticipate that the financial impact of this statement will have a material effect on our consolidated financial statements.

In July 2002, the FASB issued SFAS No. 146,Accouting for Costs Associated with Exit of Disposal Activities, which provides guidance on the recognition and measurement of liabilities associated with exit and disposal activities. Under SFAS 146, liabilities for costs associated with exit or disposal activities should be recognized when the liabilities are incurred and measured at fair value. This statement is effective prospectively for exit or disposal activities initiated after December 31, 2002. We do not anticipate that the financial impact of this statement will have a material effect on our consolidated financial statements.
Special Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as

amended. These statements relate to expectations concerning matters that are not historical facts. Such forward-looking statements may be identified by words such as “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” or “will” or the negative of these terms or other comparable terminology. These statements and all phases of our operations are subject to known and unknown risks, uncertainties and other factors, some of which are identified herein and in our Forms S-1Annual Report on Form 10-K for the year ended December 31, 2001, filed with the Securities and Exchange Commission on November 12, 2001 (File No. 333-65168) and April 25, 2002 (File No. 333-86952).Commission. Readers are cautioned not to place undue reliance on these forward-looking statements. Our actual results, levels of activity, performance or achievements and those of our industry may be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. We undertake no obligation to update the forward-looking statements in this filing. References in this filing to “AMN Healthcare,” the “Company,” “we,” “us” and “our” refer to AMN Healthcare Services, Inc. and its subsidiaries.
 
Item 3.Quantitative and Qualitative Disclosures about Market Risk

Market risk is the risk of loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates and commodity prices. Our primaryWe do not believe that we have any material market risk exposure with respect to derivative or other financial instruments. At June 30, 2002, our exposure to market risk has beenrelated primarily to changes in interest rate risk associated withrates on our debt instruments. In instances whereinvestment portfolio. Our short-term investments consist primarily of fixed income securities. We only invest in high credit quality issuers and we do not use derivative financial instruments in our investment portfolio. We do not believe that a significant increase or decrease in interest rates would have had variable (floating) rate debt, we attempted to minimizea material adverse impact on the fair value of our interest rate risk by entering into interest rate swap or cap instruments. Our corporate policy is to enter into derivative instruments only if the purpose of such instruments is to hedge a known underlying risk. We have held no derivatives instruments since our initial public offering in November 2001.

investment portfolio.

A 1% change in interest rates on variable rate debt would have resulted in interest expense fluctuating approximately $29,000$28,000 for the threesix months ended March 31,June 30, 2001. During the threesix months ended March 31,June 30, 2002, we had no outstanding debt. A 1% change in the interest rates on short-term investments would have resulted in no fluctuation in interest income for the threesix months ended March 31,June 30, 2001 and fluctuating byfluctuations of approximately $37,000$30,000 for the threesix months ended MarchJune 30, 2002.

PART II—OTHER INFORMATION
We held our Annual Meeting of Stockholders on May 31, 2002.

14

PART II — OTHER INFORMATION

Item 2.     Changes in Securities and Use of Proceeds

On January 17, 2002, we issued options The matters submitted to purchase an aggregate of 629,500 shares of common stock to some of our directors and members of management at an exercise price of $22.98 per share. The issuances were exempt from registration by virtue of Section 4(2)a vote of the Securities ActCompany’s stockholders were (i) the election of 1933,six directors to the Company’s Board of Directors and (ii) ratification of the selection of KPMG LLP as amended,the Company’s independent auditors for the fiscal year ending December 31, 2002.

The Company’s stockholders elected the following six directors to the Company’s Board of Directors, to hold office until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified. The results of the voting were as transactions not involving a public offering.follows:

Name
 
Votes For
 
Votes Withheld
Robert B. Haas 39,904,453 2,302,791
Steven C. Francis 39,904,453 2,302,791
Michael R. Gallagher 42,027,021 180,223
William F. Miller III 42,027,021 180,223
Andrew M. Stern 42,027,021 180,223
Douglas D. Wheat 42,006,121 201,123
The Company’s stockholders also ratified the selection of KPMG LLP as the Company’s independent auditors for the fiscal year ending December 31, 2002. The results of the voting were as follows:
Votes For
 
Votes Against
 
Votes Withheld
41,806,695 398,029 2,520
(a)    List of Exhibits
Exhibit
No.
  
Exhibit
No.
Description of Document
10.1  2001 Stock Option Plan Stock Option Agreement, dated as of January 17, 2002, between the Registrant and Steven Francis.*
10.22001 Stock Option Plan Stock Option Agreement, dated as of January 17, 2002, between the Registrant and Susan Nowakowski.*
10.32001 Stock Option Plan Stock Option Agreement, dated as of January 17, 2002, between the Registrant and Don Myll.*
10.42001 Stock Option Plan Stock Option Agreement, dated as of January 17, 2002, between the Registrant and Michael Gallagher.*
10.52001 Stock Option Plan Stock Option Agreement, dated as of January 17, 2002, between the Registrant and William Miller.*
10.62001 Stock Option Plan Stock Option Agreement, dated as of January 17, 2002, between the Registrant and Andrew Stern.*
10.7FirstSecond Amendment, dated as of April 8,May 2, 2002, to the Amended and Restated Credit Agreement, dated as of November 16, 2001, by and among AMN Healthcare, Inc., as borrower, the Registrant,AMN Healthcare Services, Inc., Worldview Healthcare, Inc. and O’Grady-Peyton International (USA), Inc., as guarantors, and the lenders party thereto.**
10.899.1  Office Lease, datedCertification by Steven Francis pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of April 2, 2002, between Kilroy Realty, L.P. and AMN Healthcare, Inc..*the Sarbanes-Oxley Act of 2002*
10.999.2  Stock Purchase Agreement, datedCertification by Donald Myll pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of April 17, 2002, by and among AMN Healthcare, Inc., Sandra Gilbert, Robert Gilbert, Jr., Suzette Marek, Robert Gilbert III and Benjamin Gilbert.*the Sarbanes-Oxley Act of 2002*
10.10* AMN Healthcare, Inc. Executive Nonqualified Excess Plan.*Filed herewith.
10.11** Amendment to AMN Healthcare, Inc. Executive Nonqualified Excess Plan.*
21.1Subsidiaries of the Registrant.*

* (incorporatedIncorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-1 (File No. 333-86952)).

(b)    Reports on Form 8-K: No report
On May 17, 2002, we filed a Current Report on Form 8-K wasannouncing the pricing of our secondary offering of 10,000,000 shares of common stock.
On May 2, 2002, we filed duringa Current Report on Form 8-K announcing the quarter ended March 31, 2002.

15

completion of our purchase of Healthcare Resource Management Corporation.

SIGNATURES

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: August 13, 2002
AMN HEALTHCARE SERVICES, INC.
  AMN HEALTHCARE SERVICES, INC.
Date: April 26, 2002
/s/ STEVEN FRANCIS
S/    STEVEN FRANCIS
  
Name:
Steven Francis
  
Title:
Director, President and Chief Executive Officer
Date: April 26, 2002/s/ DONALD MYLL
Date: August 13, 2002
  
/S/    DONALD MYLL
  
Name:
Donald Myll
  
Title:
Chief Financial Officer and Treasurer
(principal financial and accounting officer)

16

18